Gts Securities LLC Abb Vie Inc. Call Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $2.43 Million - $2.84 Million	15,700 Added 9.35%	183,700 $31.5 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $16.9 Million - $19.2 Million	-105,500 Reduced 38.57%	168,000 $30.6 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $1.79 Million - $2.01 Million	13,000 Added 4.99%	273,500 $42.4 Million
Q3 2023 Nov 15, 2023	BUY	$133.59 - $154.65 $34.8 Million - $40.3 Million	260,500 New	260,500 $38.8 Million

3,693

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.